BTiger I can't see this happening with cardiocel as the technology is applied to many other applications and in future may out strip the cardiovascular for revenue. The other companies that were bought seem to be products more solely aimed at cardiovascular. But a good point u make
The New Admedus, page-30
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.20 |
Change
-0.290(2.32%) |
Mkt cap ! $257.9M | |||
| Open | High | Low | Value | Volume |
| $12.49 | $12.50 | $11.80 | $396.0K | 32.70K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 923 | $11.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.20 | 1821 | 1 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |